Hawaii Biotech Awarded Grant To Develop Chikungunya Virus Vaccine

Hawaii Biotech Awarded Grant To Develop Chikungunya Virus Vaccine


The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded Hawaii Biotech, Inc. a Small Business Innovation Research Phase I grant to develop a vaccine to protect against infection caused by the mosquito-borne chikungunya virus. Chikungunya virus is transmitted by the bite of the Aedes aegypti mosquito, the mosquito that also transmits dengue and Zika virus.



from Biotech News